Pharmacokinetic/pharmacodynamic studies in drug product development

Area of Science:

• Pharmacology
• Drug Development
• Biostatistics

Background:

• Drug development is complex and costly.
• Pharmacokinetic/pharmacodynamic (PK/PD) modeling offers a promising approach to streamline this process.

Purpose of the Study:

• To highlight the multifaceted applications of PK/PD concepts throughout preclinical and clinical drug development.
• To emphasize the role of PK/PD in rationalizing and accelerating the drug development pipeline.

Main Methods:

• Application of PK/PD modeling in preclinical studies for in vivo potency and marker identification.
• Utilizing PK/PD in clinical studies to characterize dose-concentration-effect relationships and variability.
• Employing predictive PK/PD for data extrapolation, response simulation, and clinical trial forecasting.

Main Results:

• PK/PD enables evaluation of in vivo potency, bio-marker identification, and dosage optimization in preclinical stages.
• Clinical applications include characterizing dose-response, drug interactions, and inter-individual variability.
• Predictive PK/PD facilitates extrapolation, simulation, and forecasting for clinical trials.

Conclusions:

• Rigorous PK/PD implementation provides a scientific framework for efficient drug candidate selection.
• PK/PD enhances information gain from studies and supports fewer, more focused clinical trials.
• PK/PD concepts are crucial for streamlining future drug development processes, improving efficiency and cost-effectiveness.